
Gandeeva Therapeutics is a precision biotechnology company that leverages artificial intelligence and cryogenic electron microscopy (cryo-EM) to discover and develop life-changing therapies for challenging diseases. Their platform identifies target protein interfaces, then utilizes advanced AI and structural insights from cryo-EM to create superior therapeutics. They are developing a pipeline of proximity-inducing glues in oncology, aiming to modulate protein interactions for precision medicine. The company is composed of an interdisciplinary team of structural biologists, computer scientists, medicinal chemists, and industry veterans.

Gandeeva Therapeutics is a precision biotechnology company that leverages artificial intelligence and cryogenic electron microscopy (cryo-EM) to discover and develop life-changing therapies for challenging diseases. Their platform identifies target protein interfaces, then utilizes advanced AI and structural insights from cryo-EM to create superior therapeutics. They are developing a pipeline of proximity-inducing glues in oncology, aiming to modulate protein interactions for precision medicine. The company is composed of an interdisciplinary team of structural biologists, computer scientists, medicinal chemists, and industry veterans.